ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254.SZ)
300254.SZ Stock Price Chart
Explore ShanXi C&Y Pharmaceutical Group Co., Ltd. interactive price chart. Choose custom timeframes to analyze 300254.SZ price movements and trends.
300254.SZ Company Profile
Discover essential business fundamentals and corporate details for ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
19 Aug 2011
Employees
1.23K
Website
https://www.cy-pharm.comCEO
Qun Zhao
Description
ShanXi C&Y Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China, the United States, Hong Kong, and internationally. It offers products for pregnant women and babies; urinary system products; anti-infection products; traditional Chinese medicines; and dermatology products, as well as tea bags. The company was formerly known as Shanxi C&Y Pharmaceutical Co., Ltd. and changed its name to Shanxi C&Y Pharmaceutical Group Co., Ltd. in September 2014. Shanxi C&Y Pharmaceutical Group Co., LTD. was founded in 2005 and is headquartered in Shanghai, China.
300254.SZ Financial Timeline
Browse a chronological timeline of ShanXi C&Y Pharmaceutical Group Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 18 Apr 2025
EPS came in at -¥0.01 , while revenue for the quarter reached ¥237.79M .
Earnings released on 14 Apr 2025
EPS came in at ¥0.04 , while revenue for the quarter reached ¥181.74M .
Earnings released on 23 Oct 2024
EPS came in at ¥0.04 , while revenue for the quarter reached ¥207.70M .
Earnings released on 28 Aug 2024
EPS came in at ¥0.06 , while revenue for the quarter reached ¥211.62M .
Earnings released on 12 Apr 2024
EPS came in at ¥0.08 , while revenue for the quarter reached ¥187.91M .
Earnings released on 18 Mar 2024
EPS came in at ¥0.16 , while revenue for the quarter reached ¥227.37M .
Earnings released on 23 Feb 2024
EPS came in at ¥0.04 , while revenue for the quarter reached ¥206.36M .
Earnings released on 30 Jun 2023
EPS came in at -¥0.09 , while revenue for the quarter reached ¥182.40M .
Earnings released on 31 Mar 2023
EPS came in at -¥0.01 , while revenue for the quarter reached ¥183.19M .
Earnings released on 1 Jan 2023
EPS came in at -¥0.39 , while revenue for the quarter reached ¥195.14M .
Earnings released on 30 Sept 2022
EPS came in at -¥0.01 , while revenue for the quarter reached ¥228.90M .
Earnings released on 30 Jun 2022
EPS came in at -¥0.09 , while revenue for the quarter reached ¥213.22M .
Earnings released on 31 Mar 2022
EPS came in at -¥0.01 , while revenue for the quarter reached ¥191.74M .
Earnings released on 31 Dec 2021
EPS came in at -¥0.38 , while revenue for the quarter reached ¥212.92M .
Earnings released on 30 Sept 2021
EPS came in at -¥0.01 , while revenue for the quarter reached ¥259.63M .
Earnings released on 30 Jun 2021
EPS came in at -¥0.02 , while revenue for the quarter reached ¥234.75M .
Earnings released on 27 Apr 2021
EPS came in at -¥0.61 , while revenue for the quarter reached ¥248.46M .
Earnings released on 31 Mar 2021
EPS came in at ¥0.00 , while revenue for the quarter reached ¥223.08M .
Earnings released on 30 Sept 2020
EPS came in at -¥0.23 , while revenue for the quarter reached ¥204.99M .
300254.SZ Stock Performance
Access detailed 300254.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.